CINECA IRIS Institutional Research Information System
IRIS è il sistema di gestione integrata dei dati della ricerca (persone, progetti, pubblicazioni, attività) adottato dall'Università degli Studi di Torino.
AperTO è l'archivio istituzionale Open Access destinato a raccogliere, rendere visibile e conservare la produzione scientifica dell'Università degli Studi di Torino.
ItalianoSCIASCIA, Savino
Pubblicazioni
Risultati 1 - 20 di 177 (tempo di esecuzione: 0.001 secondi).
| Titolo | Data di pubblicazione | Autore(i) | |
|---|---|---|---|
| 1 | 14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends | 2014 | Bertolaccini, Maria Laura; Amengual, Olga; Andreoli, Laura; Atsumi, Tatsuya; Chighizola, Cecilia B.; Forastiero, Ricardo; de Groot, Philip; Lakos, Gabriella; Lambert, Marc; Meroni, Pierluigi; Ortel, Thomas L.; Petri, Michelle; Rahman, Anisur; Roubey, Robert; Sciascia, Savino; Snyder, Melissa; Tebo, Anne E.; Tincani, Angela; Willis, Rohan |
| 2 | A 4 Plus 2 Infusion Protocol of Rituximab Provides Long-Term Beneficial Effects in Patients with HCV-Associated Mixed Cryoglobulinemia with Membranoproliferative Nephritis and Severe Polyneuropathy. | 2012 | Roccatello, D; Sciascia, S; Baldovino, S; Rossi, D |
| 3 | The "4 plus 2" rituximab protocol makes maintenance treatment unneeded in patients with refractory ANCA-associated vasculitis: A 10 years observation study | 2017 | Roccatello, Dario; Sciascia, Savino; Rossi, Daniela; Alpa, Mirella; Naretto, Carla; Radin, Massimo; Fenoglio, Roberta; Baldovino, Simone; Menegatti, Elisa |
| 4 | A 4-year observation in lupus nephritis patients treated with an intensified B-lymphocyte depletion without immunosuppressive maintenance treatment-Clinical response compared to literature and immunological re-assessment | 2015 | Roccatello, Dario; Sciascia, Savino; Baldovino, Simone; Rossi, Daniela; Alpa, Mirella; Naretto, Carla; Di Simone, Debora; Simoncini, Matteo; Menegatti, Elisa |
| 5 | 8-Isoprostane, prostaglandin E2, C-reactive protein and serum amyloid A as markers of inflammation and oxidative stress in antiphospholipid syndrome: a pilot study. | 2012 | Sciascia S; Roccatello D; Bertero MT; Di Simone D; Cosseddu D; Vaccarino A; Bazzan M; Rossi D; Garcia-Fernandez C; Ceberio L; Stella S; Menegatti E; Baldovino S. |
| 6 | Acute kidney injury associated with glomerular diseases | 2019 | Fenoglio R.; Sciascia S.; Baldovino S.; Roccatello D. |
| 7 | The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: Results from the APS ACTION cohort | 2019 | Radin M.; Sciascia S.; Erkan D.; Pengo V.; Tektonidou M.G.; Ugarte A.; Meroni P.; Ji L.; Belmont H.M.; Cohen H.; Ramires de Jesus G.; Branch D.W.; Fortin P.R.; Andreoli L.; Petri M.; Rodriguez E.; Rodriguez-Pinto I.; Knight J.S.; Atsumi T.; Willis R.; Gonzalez E.; Lopez-Pedrera R.; Rossi Gandara A.P.; Borges Gualhardo Vendramini M.; Banzato A.; Sevim E.; Barbhaiya M.; Efthymiou M.; Mackie I.; Bertolaccini M.L.; Andrade D. |
| 8 | The adjusted Global AntiphosPholipid Syndrome Score (aGAPSS) for risk stratification in young APS patients with acute myocardial infarction | 2017 | Radin, Massimo; Schreiber, K.; Costanzo, P.; Cecchi, I.; Roccatello, Dario; Baldovino, Simone; Bazzan, M.; Cuadrado, M. J.; Sciascia, Savino |
| 9 | Allergy to buckwheat: an emerging clinical problem. Clinical and laboratory analysis of 24 consecutive patients | 2009 | Heffler, E; Asero, R; Nebiolo, F; Pizzimenti, S; Sciascia, S; Badiu, I; Guida, G; Mistrello, G; Amato, S; Marchese, C; Rolla, G |
| 10 | Anti-beta-2-glycoprotein I domain 1 identifies antiphospholipid antibodies-related injuries in patients with concomitant lupus nephritis | 2020 | Sciascia S.; Radin M.; Cecchi I.; Fenoglio R.; De Marchi A.; Besso L.; Baldovino S.; Rossi D.; Miraglia P.; Rubini E.; Roccatello D. |
| 11 | Anti-beta-2-glycoprotein I domain 1 identifies antiphospholipid antibodies-related injuries in patients with concomitant lupus nephritis | 2020 | Sciascia S.; Radin M.; Cecchi I.; Fenoglio R.; De Marchi A.; Besso L.; Baldovino S.; Rossi D.; Miraglia P.; Rubini E.; Roccatello D. |
| 12 | Anti-prothrombin (aPT) and anti-phosphatidylserine/prothrombin (aPS/PT) antibodies and the risk of thrombosis in the antiphospholipid syndrome. A systematic review. | 2013 | Sciascia S;Sanna G;Murru V;Roccatello D;Khamashta MA;Bertolaccini ML |
| 13 | Antibodies to phosphatidylserine/prothrombin complex and the antiphospholipid syndrome | 2014 | Sciascia, S.; Bertolaccini, M.L. |
| 14 | Anticardiolipin and anti-beta 2 glycoprotein-I antibodies disappearance in patients with systemic lupus erythematosus and antiphospholipid syndrome while on belimumab | 2018 | Sciascia, Savino*; Rubini, Elena; Radin, Massimo; Cecchi, Irene; Rossi, Daniela; Roccatello, Dario |
| 15 | Anticoagulation in patients with concomitant lupus nephritis and thrombotic microangiopathy: A multicentre cohort study | 2019 | Sciascia, Savino; Yazdany, Jinoos; Dall'Era, Maria; Fenoglio, Roberta; Radin, Massimo; Aggarwal, Ishita; Cuadrado, Maria J.; Schreiber, Karen; Barreca, Antonella; Papotti, Mauro; Roccatello, Dario |
| 16 | Antiphosphatidylserine/prothrombin antibodies in systemic lupus erythematosus. | 2013 | Bertolaccini ML;Sciascia S;Sanna G;Khamashta MA |
| 17 | Antiphosphatidylserine/Prothrombin Antibodies: An Update on Their Association with Clinical Manifestations of Antiphospholipid Syndrome | 2020 | Radin M.; Foddai S.G.; Cecchi I.; Rubini E.; Schreiber K.; Roccatello D.; Bertolaccini M.L.; Sciascia S. |
| 18 | Antiphospholipid antibodies: crossroads between autoimmunity and infections? | 2017 | Sciascia, Savino; Radin, Massimo; Bazzan, Mario; Roccatello, Dario |
| 19 | Antiphospholipid syndrome | 2016 | Khamashta, M.; Taraborelli, M; Sciascia, S.; Tincani, A. |
| 20 | Antiphospholipid syndrome | 2018 | Schreiber K.; Sciascia S.; De Groot P.G.; Devreese K.; Jacobsen S.; Ruiz-Irastroza G.; Salmon J.E.; Shoenfeld Y.; Shovman O.; Hunt B.J. |
Dettaglio
SCIASCIA, Savino
SCIENZE CLINICHE E BIOLOGICHE
Copyright © 2020